# Filing Detail

Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-14-004725
Filing Date
2014-07-07
Accepted
2014-07-07 17:07:49
Documents
7
Effectiveness Date
2014-07-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REGISTRATION STATEMENT | fs82014_actiniumpharma.htm | S-8 | 557746
2 | SPECIMEN COMMON STOCK CERTIFICATE | fs82014ex4i_actiniumpharma.htm | EX-4.1 | 2011
3 | OPINION OF HISCOCK & BARCLAY, LLP | fs82014ex5i_actiniumpharma.htm | EX-5.1 | 10328
4 | CONSENT OF GBH CPAS, PC | fs82014ex23i_actiniumpharma.htm | EX-23.1 | 3463
5 |  | img1.jpg | GRAPHIC | 414310
6 |  | img02.jpg | GRAPHIC | 302409
7 |  | logo.jpg | GRAPHIC | 7982
| Complete submission text file | 0001213900-14-004725.txt |  | 1573428

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-197283 | Film No.: 14963533
SIC: 6770 Blank Checks